Skip to main content

Find Clinical Trials

Home
Conditions
Thrombocytopenia

Clinical trial condition

Thrombocytopenia

Explore clinical trials studying Thrombocytopenia. Study availability and eligibility vary by location and protocol.

267 public trials 38 recruiting studies

Refine in advanced search Browse all conditions

Thrombocytopenia trial results

Completed

A Rollover Study to Provide Continued Treatment With Eltrombopag

NCT01957176

Conditions: Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +23 more
Locations: Novartis Investigative Site Leuven, Belgium

Novartis Investigative Site Shanghai, China

Novartis Investigative Site Paris, France

Novartis Investigative Site Athens, Greece

View all 13 locations

View Trial Details

Completed

An Open Label Study of Romiplostim in Adult Thrombocytopenic Subjects With ITP

NCT00508820

Conditions: Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +21 more
Locations: Not specified

View Trial Details

Completed

AMG 531 Treatment of Thrombocytopenic Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP) Prior to Splenectomy

NCT00102336

Conditions: Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations: Not specified

View Trial Details

Completed

P3 Study to Evaluate Efficacy and Safety of AMG 531 in Thrombocytopenic Japanese Subjects With Immune (Idiopathic) Thrombocytopenic Purpura

NCT00603642

Conditions: Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations: Not specified

View Trial Details

Completed

Romiplostim (AMG 531) Versus Medical Standard of Care for Immune (Idiopathic) Thrombocytopenic Purpura

NCT00415532

Conditions: Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +22 more
Locations: Not specified

View Trial Details

Completed

AMG 531 Treatment of Thrombocytopenic Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP) Refractory to Splenectomy

NCT00102323

Conditions: Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations: Not specified

View Trial Details

Completed

Romiplostim Treatment of Thrombocytopenia in Subjects With Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS)

NCT00614523

Conditions: Blood Platelet Disorders, Bone Marrow Diseases, Cytopenia, +5 more
Locations: Not specified

View Trial Details

Completed

Safety of Acupuncture and Intracutaneous Needles in Pediatric Cancer Patients: a Retrospective Study (ACUSAFE2021)

NCT05585463

Conditions: Agranulocytosis, Bacteremia, Bacterial Infections, +19 more
Locations: Hospital Sant Joan de Deu Esplugues de Llobregat, Barcelona, Spain

View Trial Details

Completed

Study on Bone Marrow Morphology in Adults Receiving Romiplostim for Treatment of Thrombocytopenia Associated With Immune Thrombocytopenia Purpura (ITP)

NCT00907478

Conditions: Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations: Not specified

View Trial Details

Completed

Observational Study of Elizaria® in aHUS Patients

NCT04749810

Conditions: Anemia, Anemia, Hemolytic, Atypical Hemolytic Uremic Syndrome, +21 more
Locations: Federal State Budgetary Educational Institution of Higher Education "Kazan State Medical University" of the Ministry of Health of the Russian Federation Kazan', Russia

Regional State Budgetary Healthcare Institution "Krasnoyarsk' Regional Clinical Center for Maternity and Childhood Protection" Krasnoyarsk, Russia

State budgetary healthcare institution of the city of Moscow "Children's City Clinical Hospital of St. Vladimir of the Healthcare Department of the City of Moscow" Moscow, Russia

Federal State Autonomous Educational Institution of Higher Education "First Moscow State Medical University n.a. I.M. Sechenov" of the Ministry of Health of the Russian Federation Moscow, Russia

View Trial Details